Transfusion transmitted human T-lymphotropic virus infections

Area of Science:

• Virology
• Epidemiology
• Public Health

Background:

• Human immunodeficiency virus (HIV) type 1 became a significant transfusion-transmitted agent in the 1980s.
• Understanding HIV's impact requires examining its epidemiology, viral characteristics, and serological responses.
• The efficacy of serological tests is crucial for identifying infected blood units.

Purpose of the Study:

• To describe the factors influencing the impact of HIV type 1 as a transfusion-transmitted agent.
• To assess the current risk of acquiring HIV through blood transfusions in Scandinavia and the Western world.
• To identify strategies for further minimizing transfusion-related HIV transmission.

Main Methods:

• Review of epidemiological data on HIV type 1.
• Analysis of serological response patterns in HIV-infected individuals.
• Evaluation of the efficacy of current anti-HIV screening tests.

Main Results:

• The risk of acquiring HIV via screened blood transfusions is now extremely low in Scandinavia and the Western world.
• Enhanced screening tests and improved donor information can further minimize residual risks.
• The epidemiology of other human T-lymphotrophic viruses (HTLV-1 and HIV-2) in Scandinavia requires further investigation.

Conclusions:

• Current anti-HIV screening has made transfusion a very safe practice regarding HIV transmission in developed regions.
• Continuous improvement in screening sensitivity and donor awareness are key to maintaining blood safety.
• Further epidemiological studies are essential for other related retroviruses like HTLV-1 and HIV-2.